RPS14 and myelodysplastic syndrome associated with isolated del(5q): Pifithrin-α restores erythroid differentiation of Rps14/19-depleted CD34+ hematopoietic stem cells in vitro, indicating its potential in reversing the erythropoietic defects in DBA or 5q– syndrome [125].